Please login to the form below
J&J's Simponi wins FDA approval in ulcerative colitis
Adds to rheumatoid arthritis, psoriatic arthritis and active ankylosing spondylitis indications in the US
Sanofi plans to file JAK2 inhibitor after positive phase III
Aiming for approval in blood cancer myelofibrosis
Bayer boosts consumer care business with Steigerwald purchase
Fuels ambition to become world leader in OTC medicines
NICE recommends Astellas' Betmiga for overactive bladder
Final draft guidance recommends Vesicare successor
Amgen and Novartis partner with biotech venture capital firm
Merck KGaA forges clinical alliance with Quintiles
CRO becomes sole outsourcing partner for pharma company
FDA clears Bayer/ Algeta's prostate cancer radiotherapy
Approval for Xofigo comes three months ahead of schedule
Video for neglected tropical diseases challenges viewers
Non-profit organisation END7 asks: 'Can you watch what they watched?'
Novo Nordisk: Strict US regulation threatens innovation
Warning from CEO Sorensen comes after Tresiba and Ryzodeg fail to win FDA approval
From paralysis to analysis: the journey to multichannel marketing
To make most of multichannel strategy, companies must be proactive and pull multichannel planning into the strategic process much earlier
-
Bringing trial data out of the shadowsTransparency of clinical trial data has become a hotly disputed topic recently, how the industry at large will respond is still not clear, but as the noise grows louder, reputations
-
The science and art of good forecastingReliable forecasting will not only allow businesses to better understand their operations, but will also help buffer against the impact of uncertainties
-
Sanofi fined for slamming Plavix genericsFaces €40.6m penalty for telling doctors generic copies were not suitable substitutes for blockbuster antiplatelet drug
-
FDA expands use of Roche/ Astellas’ Tarceva in lung cancer patientsNew indication approved alongside companion diagnostic to detect gene mutation
-
Merck KGaA to meet 2014 financial targets one year earlyBut continued growth of Rebif under threat from new oral MS drugs
-
GSK partners with Save the Children to tackle child mortality in Africa
Firm will develop and distribute medicines in some of the world’s poorest countries
-
New guidelines allow brands to majority fund health campaigns
UK government departments no longer have to match funding from external partners
-
FDA starts review of Biogen Idec's haemophilia A therapyCould gain US approval by the first quarter of 2014
-
Research units to close as Astellas restructuresUS subsidiaries OSI Pharmaceuticals and Perseid Therapeutics among those affected
Latest appointments
-
Former NICE chair joins board of biotechSir Michael Rawlins joins board of Intra-Cellular Therapeutics
-
Lundbeck's Steve Turley re-elected as EMG chairAnd Actelion's Robin Bhattacherjee retains vice-chair position
-
VC firm expands team, appoints Genzyme and Lilly veteransNew roles for James Geraghty, Steven Paul, Daniel Lynch and John Maraganore
-
Damian Eade to lead Insight Research Group's new digital teamNew business team will focus on mobile, strategy and new channels
-
WorldOne promotes Eva LaparraShe becomes managing director for the UK and Northern Europe
Featured jobs
- Senior Brand Manager - Harlow
- Competitive
- Sales Manager - Media Publishing – Cheshire
- 25,000 to 35,000 per annum
- UK Marketing Director
- 80,000 to 100,000 per annum
- Group Account Director –Healthcare Advertising
- Neg
Subscribe to our email news alerts
- Achieving an aligned business intelligence capability - fact or fiction?
- Boehringer Ingelheim and Lilly launch diabetes education campaign
- Sanofi appoints Pascale Witz and Peter Guenter
- GSK to set up online system for trial data requests
- Former Google chief launches online cancer forum
- Value-based pricing "not in patient interest"
- UCB and IBM to harness big data for personalised epilepsy care
- J&J's Simponi wins FDA approval in ulcerative colitis
- Sanofi plans to file JAK2 inhibitor after positive phase III
- Bayer boosts consumer care business with Steigerwald purchase
- NICE recommends Astellas' Betmiga for overactive bladder
- Former NICE chair joins board of biotech
PMHub
Add my companyHanson Zandi
Hanson Zandi’s philosophy is to go that extra mile. Look deeper. Discuss further.Study longer. Work harder.This focussed ...
Latest intelligence
- How can pharma deliver returns on increased digital investment?
- Independent online professional networks work best as part of a multi-channel campaign ...
- The impact of Hollande's healthcare reforms in France
- A tougher environment for pharma, with market access and regulatory challenges...
- A guide to developing customer-centred, multichannel marketing
- Find out how a balanced approached to multichannel marketing could benefit your brand - the customer's agenda is just as important as Pharma's and needs to be listened to in ...
Quick links
